148 filings
Page 2 of 8
8-K
0ifsoj4l3f1dcvkgh
27 Mar 24
Regulation FD Disclosure
4:01pm
8-K
dn8 4hg2n45dl9o2da
22 Mar 24
TFF Pharmaceuticals Announces $1.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
4:25pm
424B5
uxacjirh
22 Mar 24
Prospectus supplement for primary offering
8:00am
8-K
shr8og
19 Dec 23
TFF Pharmaceuticals Announces Reverse Stock Split
6:07am
8-K
j2fyqs
15 Dec 23
TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors
4:06pm
EFFECT
bsdalr kqmn
13 Dec 23
Notice of effectiveness
12:15am
8-K
eg1r7a9
8 Dec 23
Departure of Directors or Certain Officers
4:10pm
CORRESP
8fa icq1749ev5jitit
8 Dec 23
Correspondence with SEC
12:00am
8-K
7bp 1rzkr71heyh8j
4 Dec 23
TFF Pharmaceuticals Appoints Catherine Lee, J.D. to Board of Directors
5:26pm
UPLOAD
ct7l9o wi
28 Nov 23
Letter from SEC
12:00am
8-K
y2tatmo 5ampq
22 Nov 23
Amendments to Articles of Incorporation or Bylaws
5:14pm
8-K
ix1 e1fxi57eg2ypa3e
14 Nov 23
TFF Pharmaceuticals Reports Third Quarter 2023 Financial Results
4:06pm
ARS
bm8d14zh 4nfuw9oe3
4 Oct 23
Annual report to shareholders
4:10pm
DEFA14A
fbx47n97
4 Oct 23
Additional proxy soliciting materials
4:07pm